EUVIMEDEUVIMED entdecken
Crossref

USP18 enhances the resistance of BRAF-mutated melanoma cells to vemurafenib by stabilizing cGAS expression to induce cell autophagy

Zhou-Rui Ma, Qian-Wei Xiong, Shi-Zhong Cai, Ling-Tao Ding, Chao-Hong Yin, Hong-Liang Xia, Wei Liu, Shu Dai, Yue Zhang, Zhen-Hong Zhu, Zhi-Jian Huang, Qian Wang und 1 weitere

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Zhou-Rui Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burns and Plastic Surgery, Children's Hospital of Soochow University, Suzhou 215025, PR China; Suzhou Key Laboratory of Congenital Stru…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Melanoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to discern the possible molecular mechanism of the effect of ubiquitin-specific peptidase 18 (USP18) on the resistance to BRAF inhibitor vemurafenib in BRAF V600E mutant melanoma by regulating cyclic GMP-AMP synthase (cGAS). The cancer tissues of BRAF V600E mutant melanoma patients before and after vemurafenib treatment were collected, in which the protein expression of USP18 and cGAS was determined. A BRAF V600E mutant human melanoma cell line (A2058R) resistant to vemurafenib was constructed with its viability, apoptosis, and autophagy detected following overexpression and depletion assays of USP18 and cGAS. Xenografted tumors were transplanted into nude mice for in vivo validation. Bioinformatics analysis showed that the expression of cGAS was positively correlated with USP18 in melanoma, and USP18 was highly expressed in melanoma. The expression of cGAS and USP18 was up-regulated in cancer tissues of vemurafenib-resistant patients with BRAF V600E mutant melanoma. Knockdown of cGAS inhibited the resistance to vemurafenib in A2058R cells and the protective autophagy induced by vemurafenib in vitro. USP18 could deubiquitinate cGAS to promote its protein stability. In vivo experimentations confirmed that USP18 promoted vemurafenib-induced protective autophagy by stabilizing cGAS protein, which promoted resistance to vemurafenib in BRAF V600E mutant melanoma cells. Collectively, USP18 stabilizes cGAS protein expression through deubiquitination and induces autophagy of melanoma cells, thereby promoting the resistance to vemurafenib in BRAF V600E mutant melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafMelanomaAnimalsMiceHumansVemurafenibMice, NudeIndolesSulfonamidesDrug Resistance, NeoplasmMutationCell Line, TumorProtein Kinase InhibitorsAutophagyNucleotidyltransferasesUbiquitin Thiolesterase

Stichwörter der Autor:innen

AutophagyBRAF V600E mutant melanomaDeubiquitinationUSP18Vemurafenib resistancecGAS

Substanzen

VemurafenibProto-Oncogene Proteins B-rafIndolesSulfonamidesProtein Kinase InhibitorsNucleotidyltransferasesBRAF protein, humanUSP18 protein, humanUbiquitin Thiolesterase

Autor:innen und Institutionen

  • Department of Burns and Plastic Surgery, Children's Hospital of Soochow University, Suzhou 215025, PR China; Suzhou Key Laboratory of Congenital Structural Deformities, Suzhou 215025, Jiangsu, PR China.
  • Suzhou Key Laboratory of Congenital Structural Deformities, Suzhou 215025, Jiangsu, PR China; Department of Urology, Children's Hospital of Soochow University, Suzhou 215025, PR China.
  • Suzhou Key Laboratory of Congenital Structural Deformities, Suzhou 215025, Jiangsu, PR China; Department of Child and Adolescent Healthcare, Children's Hospital of Soochow University, Suzhou 215025, PR China.
  • Department of Burn and Plastic Surgery, Affiliated Hospital of Jiangnan University, Wuxi 214000, PR China.
  • Department of Burns and Plastic Surgery, Children's Hospital of Soochow University, Suzhou 215025, PR China.
  • Suzhou Key Laboratory of Congenital Structural Deformities, Suzhou 215025, Jiangsu, PR China.

Zitieren

APA

Ma, Z. R., Xiong, Q. W., Cai, S. Z., Ding, L. T., Yin, C. H., Xia, H. L., Liu, W., Dai, S., Zhang, Y., Zhu, Z. H., Huang, Z. J., Wang, Q., & Yan, X. M. (2023). USP18 enhances the resistance of BRAF-mutated melanoma cells to vemurafenib by stabilizing cGAS expression to induce cell autophagy. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110617

Vancouver

Ma ZR, Xiong QW, Cai SZ, Ding LT, Yin CH, Xia HL, et al. USP18 enhances the resistance of BRAF-mutated melanoma cells to vemurafenib by stabilizing cGAS expression to induce cell autophagy. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110617

BibTeX
@article{Ma2023,
  author = {Ma, Zhou-Rui and Xiong, Qian-Wei and Cai, Shi-Zhong and Ding, Ling-Tao and Yin, Chao-Hong and Xia, Hong-Liang and Liu, Wei and Dai, Shu and Zhang, Yue and Zhu, Zhen-Hong and Huang, Zhi-Jian and Wang, Qian and Yan, Xiang-Ming},
  title = {USP18 enhances the resistance of BRAF-mutated melanoma cells to vemurafenib by stabilizing cGAS expression to induce cell autophagy},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110617}
}
Kostenlos starten →